USD 2.04 Billion
Venous Stents Market Size, Share, and Growth Analysis
Venous Stents Market By Type (Self-Expandable, Balloon-Expandable, Covered), By Material (Metallic, Polymers, Biodegradable), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Region -Industry Forecast 2025-2032
Report ID:
SQMIG35A3037 |
Region:
Global |
Published Date: May, 2025
Pages:
198
|Tables:
90
|Figures:
70
Format -
Venous Stents Market Insights
Global Venous Stents Market size was valued at USD 2.04 Billion in 2023 and is poised to grow from USD 2.13 Billion in 2024 to USD 3.06 Billion by 2032, growing at a CAGR of 4.62% in the forecast period (2025-2032).
The global venous stents market growth is being driven by a variety of factors, from increasing venous disease incidence to growing aging populations. As more patients seek effective treatment of diseases such as chronic venous insufficiency and deep vein thrombosis, demand for stenting solutions grows. Technological progress in stent technology through design and material is enabling better clinical outcomes, driving further market growth.
- For instance, the July 2024 approval of the Zilver PTX Drug-Eluting Stent demonstrates how innovation in stent technology, such as the integration of drug-eluting functionality to reduce restenosis, is fueling market growth. This technology addresses the demand for improved treatment options, improving patient outcomes, and keeping up with the trend of minimally invasive treatments that reduce recovery time and complications.
In addition, increasing patient and healthcare provider awareness of venous diseases is propelling the overall expansion of the global venous stents sector.
What Impact Does AI Have on Minimizing Risks in Venous Stent Treatments?
Through enhanced diagnosis, treatment planning, and stent design, artificial intelligence is increasingly revolutionizing the global venous stent industry. Through AI-based imaging technology, precise venous stent implantation is achieved, allowing physicians to analyze diagnostic images such as CT scans and ultrasounds more extensively. Through patient data analysis and stent recommendation, AI facilitates personalized treatment regimens. AI also enhances material design and stent design to enhance clinical outcomes.
- For instance, AI-powered vascular imaging technology that Siemens Healthineers launched in March 2024 improves detection and treatment of venous disease by helping doctors make better decisions regarding the insertion of venous stents. The invention accelerates patients' recovery and alleviates issues.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Metallic
Fastest Growth
Biodegradable
Growth Rate
4.62% CAGR
Global Venous Stents Market ($ Bn)
Country Share for North America (%)
To get more reports on the above market click here to Buy The Report
Venous Stents Market Segments Analysis
The global venous stents market is segmented into type, material, end use, and region. By type, the market is classified into self-expandable, balloon-expandable, and covered. Depending on material, it is divided into metallic, polymers, and biodegradable. According to end use, the market is categorized into hospitals, ambulatory surgical centers, and specialty clinics. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
What Drives the Popularity of Self-Expandable Stents?
As per the 2024 global venous stents market analysis, since self-expandable stents are automatically open upon deployment, they are the market leader and can be applied to patients suffering from complex coronary conditions. Self-expandable stents are used extensively due to their enhanced flexibility and lower restenosis rates. As per the latest data, self-expandable stents possess a commanding market share of more than 60%, fueled by the increase in cardiovascular diseases and advancements in stent design technology, especially during 2024–2025.
The balloon-expandable category is anticipated to have the highest venous stents market share due to their application in larger arteries and the increasing demand for less invasive procedures. Balloon-expandable stents are likely to witness greater market growth due to the increasing emphasis placed on making the stents more flexible and durable. Through the year 2025, balloon-expandable stents are projected to grow at a 5–8% annual rate.
What Makes Metallic Stents the Top Choice in Vascular Treatments?
Based on the 2024 global venous stents market forecast, given their strength, longevity, and biocompatibility, metallic stents are still the most sought material in the industry, especially when it comes to coronary artery treatments. There are several materials that provide long-term performance such as titanium, cobalt-chromium, and stainless steel and are used for metallic stents. Since they keep up with increasing demand for lasting and effective options for the cure of vascular illness, especially considering the breakthrough made in 2024, more than 70% of the market is held by them.
As advances in biodegradable material and design diminish the risk of long-term issues, biodegradable stents will be poised to experience significant growth. Biodegradable stents are increasingly being used, particularly in Europe, as concerns regarding environmental sustainability and patient concerns regarding implant lifespan increase. Through 2025, biodegradable stents will grow at a rate of 10–12% per annum.
Global Venous Stents Market By Material
To get detailed analysis on other segments, Request For Free Sample Report
Venous Stents Market Regional Insights
Why Does North America Dominate the Venous Stents Market?
As per the 2024 venous stents market regional forecast, the market is led by North America due to its sophisticated health care system and increasing prevalence of chronic venous diseases. There was a drastic rise in endovascular procedures across the region in 2024, with a high occurrence in the United States alone where more than 250,000 cases of deep vein thrombosis were identified. Hospitals are being compelled to install stERA technology at a quicker pace owing to the increasing population of old patients and insurance for minimally invasive procedures.
U.S. Venous Stents Market
The U.S. venous stents market is thriving due to the enormous amount of clinical research and FDA-sanctioned technology. A novel self-expanding venous stent for iliofemoral blockages was approved by the FDA in 2024. With the backing of a patient base that's increasingly aware and demanding quicker recovery options, industry heavy hitters such as Cook Medical and Boston Scientific continue to innovate.
Canada Venous Stents Market
The Canadian venous stents market is slowly expanding because of increased investment in vascular medicine and interventional radiology. Access was expanded in 2025 when some provincial health systems started to reimburse treatment for chronic venous obstruction. Canadian hospitals are increasingly collaborating with U.S. providers for new-generation stent technology.
How Is Europe Advancing Venous Stent Adoption?
Europe has a great market share of venous stent because of the great number of procedures that occur in nations such as Germany and the UK. The region is favored with regulated medical procedures and strict regulation that stimulates innovation. Stents in hospitals have grown due to the European Society for Vascular Surgery's 2024 guidelines, which put an emphasis on early intervention of venous disease.
UK Venous Stents Market
National Health Service (NHS) programs for promoting less invasive vascular interventions are leading the UK venous stents market. Venous interventions grew by 15% in 2024 from the previous year, according to NHS England. Universities and hospitals are partnering in research and development for next-generation stents to minimize restenosis risks.
France Venous Stents Market
France keeps investing in the production of medical devices and vascular research. Over 10,000 venous stenting procedures were conducted by French vascular specialists in 2024, and academic centers embraced this treatment in large quantities. In conclusion to its economy based on innovation, France also organized MedTech conferences where companies launched bioresorbable venous stents.
Germany Venous Stents Market
Germany is a prime location for venous stent development and uptake due to its strong medical device sector and specialized hospitals. Artificial intelligence -based diagnostic imaging was utilized in German hospitals in 2025 to diagnose venous blockages and enhance stenting patient selection. Public-private partnerships are driving both export market R&D and local demand.
What Factors Are Fueling APAC Venous Stent Innovation?
As a result of increased access to vascular care, increased venous disease awareness, and increasing healthcare expenditures, Asia-Pacific is experiencing the most rapid growth in the venous stents market. India and China are driving market growth through volume and affordability, with South Korea and Japan driving clinical innovation.
Japan Venous Stents Market
Among the key drivers of Japan's venous stents market growth is Japan's rapidly growing population of aging people. In 2024, more than 29% of the population was 65 years or older, necessitating less invasive procedures. Medical universities in Japan are creating next-generation stents with anti-thrombogenic coatings to minimize complications in older patients.
South Korea Venous Stents Market
The South Korean venous stents market is growing rapidly due to both a successful commercial hospital industry and government-funded innovation initiatives. Venous stenting procedures grew by 22% each year in 2025, as reported by Seoul National University Hospital. Korean companies are also penetrating the export market with compact, affordable venous stent solutions.
Global Venous Stents Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Venous Stents Market Dynamics
Venous Stents Market Drivers
Rising Incidence of Venous Chronic Disease
- Increase in chronic venous conditions like post-thrombotic syndrome and deep vein thrombosis globally is one of the key factors driving the growth of the venous stents market. Intervention therapy can be a requirement for the treatment of specific conditions to rejuvenate blood supply and alleviate the long-term impacts. Demand for venous stents is increasing in mature and emerging healthcare markets because of better diagnosis rates and greater awareness among aging populations, which is propelling the industry's steady growth.
Advancements in Stent Design Technology
- The development of self-expanding nitinol, drug-eluting coatings, and better delivery systems are a few instances of technological advancements in venous stent design that have significantly enhanced procedural success and long-term outcomes. These advancements improve stent precise positioning, biocompatibility, and pliability. Second-generation stents are increasingly being adopted following manufacturers' research and development investments, making it possible for more personalized treatment plans for complex venous diseases and facilitating expanded clinical adoption across the globe's healthcare systems.
Venous Stents Market Restraints
Costly Stent Procedures
- Due to the expense of the devices, pre-procedure imaging, and specialist services, venous stent procedures are still expensive. Access to patients can be hindered by these costs, particularly in regions with underdeveloped reimbursement systems. In addition, the cost typically deters clinics and hospitals from implementing new stent technology. Price-sensitive markets and public healthcare systems can be challenging for the market to penetrate without increased insurance coverage and efficiency gains.
Stringent Regulatory Requirements
- Stringent regulatory rules govern the venous stents industry, particularly the acquisition of licenses from regulatory bodies such as the FDA and EMA. Development time and expense for manufacturers are enhanced by these regulations, which require rigorous clinical trials and post-market monitoring. Small companies have less opportunity to penetrate the market as a consequence, and innovation is retarded. International product launches and international market penetration could also be slowed by regional differences in regulatory procedures.
Request Free Customization of this report to help us to meet your business objectives.
Venous Stents Market Competitive Landscape
The global venous stents market is dominated by stiff competition among major players to establish market shares. Most often, competitive strategies such as product introductions, collaborations, acquisitions, and mergers are adopted. Stryker, for example, in January 2025 revealed that it will be acquiring Inari Medical for USD 4.9 billion to broaden its venous thromboembolism therapy portfolio. It demonstrates the competitiveness of the market coupled with the focus on growth and innovation.
- Oxford Endovascular (2015, UK): Oxford Endovascular, a University of Oxford spin-out, is developing stent technology based on origami to treat brain aneurysms. The nickel-titanium alloy stents are potentially foldable into less invasive packages and could be delivered through microcatheters. When deployed to repair dilated blood arteries, they expand. The technology beneath has the potential to be applied to venous procedures as well, providing new solutions for complex vascular issues, although their current focus is on neurovascular applications.
- Oxford Heartbeat (2015, UK): Oxford Heartbeat has created advanced software that creates 3D models of a patient's cerebral blood arteries using 2D medical imaging. This increases stent placement accuracy and reduces the risk of complications by allowing surgeons to model and select the best stent for each case. This method was initially used on cerebral arteries, but it could possibly be used for venous systems as well and enhance the effects of venous stenting treatment through personalized planning.
Top Player’s Company Profiles
- Boston Scientific Corporation
- Medtronic Plc
- Becton, Dickinson and Company
- Cook Medical
- Gore Medical
- Abbott Laboratories
- Vesper Medical
- Optimed Medizinische Instrumente GmbH
- BIOTRONIK SE & Co. KG
- Bentley InnoMed GmbH
- Cordis Corporation
- Plus medica GmbH & Co.
- Philips Healthcare
- Stryker Corporation
Recent Developments in Venous Stents Market
- In November 2024, Medtronic released positive results of the Optimize PRO study, which compared the cusp overlap technique with the EvolutTM Transcatheter Aortic Valve Replacement (TAVR) device. Two instances of enhanced procedural efficacy and valve performance are lower rates of new permanent pacemaker implantation and lack of moderate or severe aortic regurgitation at discharge. In addition, aggregated research validated the long-term advantages of the Evolut PRO system by demonstrating the improvement in paravalvular leak severity at three years of follow-up.
- In June 2024, Boston Scientific reported that it agreed to pay USD 1.16 billion to acquire Silk Road Medical. The best-known procedure available from Silk Road is TransCarotid Artery Revascularization (TCAR), reducing the risk of stroke and providing a minimally invasive treatment for carotid artery disease. Boston Scientific will have further penetration in the neurovascular intervention market and strengthen its vascular business through strategic acquisition.
- In April 2024, Abbott's EspritTM BTK Everolimus Eluting Resorbable Scaffold System, the dissolvable stent for arteries below the knee, was approved by the FDA. By keeping the artery open and delivering the drug everolimus to stimulate healing, the device treats chronic limb-threatening ischemia (CLTI) before breaking down slowly over a three-year time frame. Compared to balloon angioplasty, clinical trials demonstrated that Esprit BTK significantly minimized repeat procedures, providing patients with peripheral artery disease with a new therapeutic option.
Venous Stents Key Market Trends
- Transition to Less Invasive Procedures: With shorter recovery periods, fewer risks of operation, and greater patient satisfaction, there is a global trend towards less invasive venous treatments. Venous stents play a key role in these methods, especially for venous diseases like iliofemoral vein obstruction. Demand for stents compatible with less invasive techniques is increasing as healthcare economics increasingly focus on outpatient and day surgery programs. This affects hospital buying habits and product design.
- Growth in Emerging Markets: As developing healthcare facilities and public sector investment rise, emerging markets like India, Brazil, and Southeast Asia are embracing cutting-edge medical technology at a fast pace. Untapped market development opportunities are offered by growing healthcare awareness and venous disorder diagnosis in these markets. As regulatory agencies simplify procedures to offer faster access to life-saving stent therapy, multinational companies are entering these markets through joint ventures and local production.
Venous Stents Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, owing to technological developments in stents and the increased incidence of chronic venous diseases, the global venous stents market outlook is expected to change. While there are still barriers such as cost of treatment and legal issues, there is great potential in the increasing use of minimally invasive procedures and new market expansion. The market is marked by dynamic competition, with large companies aggressively pursuing strategic efforts to consolidate their market positions. Demand for successful venous stenting devices will continue to grow as patient education and healthcare systems evolve, driving innovation and business growth in the future years.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 2.04 Billion |
| Market size value in 2032 | USD 3.06 Billion |
| Growth Rate | 4.62% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Venous Stents Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Venous Stents Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Venous Stents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Venous Stents Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Venous Stents Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Venous Stents Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
